Dyeing silk organza fabrics with dyeable silk fabrics is one of the most interesting things to do with organza.Organza is the oldest, most popular type of silk fabric in the world.It has been used for centuries to make fabrics such as bags, robes, curtains, shoes, jewelry, and so on.These fabrics can be dyed in many different ways and each one has their own advantages and disadvantages.Organzas ar...
China’s most deadly drug-resistant bacteria are likely to be a rare but real problem for the world’s second-biggest economy, according to a new analysis.
It shows the global pharmaceutical industry faces a daunting challenge in dealing with the threat, a problem that is likely to worsen as China’s economy continues to struggle with a massive increase in cases.
China has the world list of the world`s most deadly drugs-resistant bacterial infections, according the United Nations, and experts say the country is likely seeing its share of cases as more countries try to control the disease.
The country is facing an outbreak of the rare but devastating bacteria called S. burchelli that is causing a surge in cases that are far exceeding the country’s capacity to contain.
The rise of S. Burchelli could put a crimp on China`s economic growth.
It is a major cause of China`S economic woes, with the country already the world economy and largest economy with a gross domestic product of $1.2 trillion.
On Tuesday, China said it would invest $50 billion to treat the S.burchelli outbreak, but the figure was far from enough to prevent the spread of the disease, which can be deadly in parts of China.
The government plans to spend about $5 billion on a new antibiotic, and has promised $50 million in additional cash, according a Chinese official who declined to be identified for fear of retaliation from the government.
But even the $50-billion figure is dwarfed by the $100 billion China has pledged to deal with its antibiotic problems.
To combat S.
Burchelli, the government has spent the last several months working to develop a new type of drug, known as a drug-based treatment, or PDT, that is more effective and less costly than standard antibiotics.
China is also trying to get a new strain of S.-resistant bacteria isolated, but experts warn the process could take months.
“China will have to fight the epidemic for the foreseeable future, with or without the aid of a PDT drug,” said Richard Condon, the deputy director of the Center for Global Health at Johns Hopkins University.
Although China has been battling the outbreak, it has also been trying to deal directly with the problems that have arisen from the outbreak.
It has announced a $100-billion fund to address the crisis, but has yet to put more money into the plan.
In its statement on Tuesday, the Chinese government said that China has also pledged to invest $10 billion in new medical research and $50,000 to support the treatment of the S.-burchellin patients.
It said China has already invested $50.5 billion in its antibiotic research program and is spending $10.5 million on additional research.
But the China Daily newspaper reported on Tuesday that Chinese scientists had tested the drug-free versions of the antibiotic sulfanilamide and metallothionein and have found no evidence that it prevents the bacteria from spreading.
Sulfanilide, which has a higher concentration of sulfate ions, is a new compound developed by Chinese scientists, the paper said.
It was designed to block the S-burchell infection and can be applied in combination with antibiotics to treat a wide range of infections.
Scientists also found that the sulfanile compounds could also be used to treat some other infections, including MRSA, a common and deadly strain of bacteria.
They have not yet identified any clinical trials to test the sulfanolamide, but are developing a drug to treat it.
Condon said China is likely hoping that the PDT will be used as a short-term solution to combat S.-Burchell infections, and that it will be cheaper than the more expensive options.
But it is also likely that the government will have more long-term plans to combat the SBurchell infection, he said.
While the Sburchell disease has spread rapidly across China, the virus has not been as widely spread in the rest of the country.
The first S.burgleni cases were reported in May.